Medication

FILE - This Friday, Oct. 10, 2008, file photo illustration shows Johnson & Johnson products, in Philadelphia. Johnson & Johnson is topping profit and revenue expectations for the first quarter partially on strong sales of its psoriasis treatment, Stelara. The New Brunswick, N.J., company on Tuesday, April 16, 2019 posted profit of $3.75 billion, or $1.39 per share. Earnings, adjusted for amortization costs and research and development costs, were $2.10 per share, or 7 cents better that Wall Street expected, according to a survey by Zacks Investment Research. (AP Photo/Matt Rourke, File)
April 16, 2019 - 8:41 am
Lower sales overseas and higher costs for research and litigation pushed Johnson & Johnson's first-quarter profit down 14%. Still, the health care giant beat profit and revenue expectations, pushing up its shares in premarket trading. The maker of Tylenol and psoriasis drug Stelara on Tuesday...
Read More
In this April 11, 2019 photo, Shelley Gillen is photographed in her Bellevue, Neb., home with her 17-year-old son, Will, who wears a helmet to protect him from damage during debilitating seizures. Gillen advocates the legalization of medical marijuana that could help her son's seizures. Nebraska's conservative lawmakers are poised to once again reject measures calling for allowing limited and highly regulated use of medical marijuana, but their decision this year could have the unintended consequence of ushering in one of the most unrestricted medical marijuana laws in the country. (AP Photo/Nati Harnik)
April 15, 2019 - 1:18 pm
LINCOLN, Neb. (AP) — Year after year, Nebraska's conservative lawmakers have rejected measures calling for limited and highly regulated medical marijuana. They're poised to do it again, but their decision this year could have the unintended consequence of ushering in one of the most unrestricted...
Read More
FILE - In this Monday, Sept. 24, 2018 file photo, a patient undergoes dialysis at a clinic in Sacramento, Calif. Results of a study released on Sunday, April 14, 2019 show that the diabetes drug Invokana has been shown to help prevent or delay worsening of kidney disease, which causes millions of deaths each year and requires hundreds of thousands of people to use dialysis to stay alive. (AP Photo/Rich Pedroncelli)
April 14, 2019 - 8:08 pm
A new study shows that a drug used to help control blood sugar in people with diabetes also can prevent or slow kidney disease, which causes millions of deaths each year and requires hundreds of thousands of people to use dialysis to stay alive. Doctors say it's hard to overstate the importance of...
Read More
In this photo provided by the New Jersey Office of the Governor, N.J. Gov. Phil Murphy signs the Medical Aid in Dying for the Terminally Ill Act Friday, April 12, 2019 at the New Jersey Statehouse in Trenton, N.J. New Jersey is the seventh state to enact a law permitting terminally ill patients to seek life ending medication. (New Jersey Office of the Governor via AP)
April 12, 2019 - 3:32 pm
TRENTON, N.J. (AP) — Gov. Phil Murphy on Friday signed legislation making New Jersey the seventh state to enact a law permitting terminally ill patients to seek life-ending medication. New Jersey will join six other states and the District of Columbia that have similar laws once it goes into effect...
Read More
FILE - This Aug. 29, 2018, file photo shows an arrangement of prescription oxycodone pills in New York. U.S. health officials Tuesday, April 9. 2019, warned doctors not to abruptly stop prescribing opioid painkillers to patients who are taking them for chronic pain ailments, such as backaches. (AP Photo/Mark Lennihan, File)
April 09, 2019 - 7:05 pm
WASHINGTON (AP) — U.S. health officials Tuesday warned doctors not to abruptly stop prescribing opioid painkillers to patients who are taking them for chronic pain ailments, such as backaches. The Food and Drug Administration said it will add advice to labels on how to taper opioid painkillers,...
Read More
Prime Therapeutics Senior Vice President, General Counsel, and Interim President and Chief Executive Officer Mike Kolar, right, testifies before the Senate Finance Committee on Capitol Hill in Washington, Tuesday, April 9, 2019, during a hearing to explore the high cost of prescription drugs. He is joined at the table by, from left, Cigna Corporation Executive Vice President and Chief Clinical Officer Steve Miller, CVS Caremark President and CVS Health Executive Vice President Derica Rice, Humana Healthcare Services Segment President William Fleming and OptumRx Chief Executive Officer John Prince. (AP Photo/Susan Walsh)
April 09, 2019 - 2:29 pm
Patient bills, competition and secrecy shared the spotlight Tuesday as pharmacy benefit managers testified before Congress about prescription drug prices. Members of a Senate Finance Committee investigating drug costs pushed the benefit managers to explain why they can't do more to control prices...
Read More
FILE - In this Friday, July 8, 2016 photo, a pharmacist holds a bottle of the antibiotic doxycycline hyclate in Sacramento, Calif. According to a study released on Monday, April 8, 2019, sniffling, coughing kids who were seen via telemedicine visits were far more likely to be prescribed antibiotics than kids who went to a doctor’s office or clinic. (AP Photo/Rich Pedroncelli)
April 08, 2019 - 9:41 am
NEW YORK (AP) — Telemedicine may be leading to the overprescribing of antibiotics to sniffling children, a new study suggests. Kids with cold symptoms seen via telemedicine visits were far more likely to be prescribed antibiotics than those who went to a doctor's office or clinic, researchers found...
Read More
FILE - In this Friday, Jan. 4, 2018 file photo, a worker adds CBD oil to a drink at a coffee shop in Fort Lauderdale, Fla. Cannabidiol is one of more than 100 compounds found in marijuana. (Jennifer Lett/South Florida Sun-Sentinel via AP)/South Florida Sun-Sentinel via AP)
April 02, 2019 - 10:09 pm
With CBD showing up everywhere, U.S. regulators announced Tuesday they are exploring ways the marijuana extract could be used legally in foods, dietary supplements and cosmetics. The U.S. Food and Drug Administration said it will hold a public hearing May 31 to gather more information on the...
Read More
In this Feb. 19, 2019 photo, a group of seniors from Laguna Woods Village check in at Bud and Bloom cannabis dispensary in Santa Ana, Calif. More Americans in their 70s and 80s are adding marijuana use to their roster of senior activities. Recent studies show that people 65 and over are the fastest-growing segment of cannabis users. (AP Photo/Jae C. Hong)
March 25, 2019 - 4:48 pm
LAGUNA WOODS, Calif. (AP) — The group of white-haired folks — some pushing walkers, others using canes — arrive right on time at the gates of Laguna Woods Village, an upscale retirement community in the picturesque hills that frame this Southern California suburb a few miles from Disneyland. There...
Read More
March 19, 2019 - 7:06 pm
TRENTON, N.J. (AP) — The U.S. Food and Drug Administration has approved the first drug specifically developed for severe depression after childbirth. The agency on Tuesday approved Sage Therapeutics' Zulresso, an IV drug given over 2 ½ days. Sage said Zulresso will cost $34,000 without insurance,...
Read More

Pages